RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Zivo Bioscience Stock

Zivo Bioscience P/S 2024

Zivo Bioscience P/S

44.56

Ticker

ZIVO

ISIN

US98978N1019

As of Dec 12, 2024, Zivo Bioscience's P/S ratio stood at 44.56, a 4,226.21% change from the 1.03 P/S ratio recorded in the previous year.

The Zivo Bioscience P/S history

Zivo Bioscience Aktienanalyse

What does Zivo Bioscience do?

Zivo Bioscience Inc is a biotechnology company that was founded in 2008. The company is based in Keego Harbor, Michigan, USA. It specializes in the development and production of animal feed, nutritional supplements, and medications from plant sources. The founders of the company recognized the potential of microalgae as a food source for animals and began conducting extensive research campaigns on this topic. The algae are rich in proteins, Omega-3, vitamins, and minerals, making them an excellent food source for livestock. Zivo Bioscience Inc's business model is based on the production of food and nutritional supplements for livestock. The company's goal is to offer a cost-effective alternative to conventional animal feed products that have higher quality and nutritional value. The company holds several patents for its technology, which allows it to develop these high-quality food products. Zivo Bioscience Inc has three different business segments: animal feed, human nutritional supplements, and pharmaceutical products. The animal feed segment is the company's largest business segment. The products include cattle feed, poultry feed, and swine feed. The human nutritional supplements are high-quality supplements made from the company's crop plants. These include products such as Omega-3 supplements, immune system boosters, and antioxidants. The pharmaceutical segment of the company focuses on the development of medications for various applications, particularly for the fight against inflammation and cancer. Zivo Bioscience Inc has launched several plant-based products on the market. The products for livestock include ZivoProtein and ZivoAlgae. ZivoProtein is a high-quality protein derived from microalgae that can be used in various animal feed products. ZivoAlgae is a blend of different microalgae species that can be used as a nutritional supplement for livestock. The products for human nutritional supplements include ZivoChews, ZivoBar, and ZivoEPA+DHA. ZivoChews and ZivoBar are snack products made from plant sources and contain various nutrients, including proteins, Omega-3 fatty acids, and antioxidants. ZivoEPA+DHA is a high-quality Omega-3 supplement. In the pharmaceutical field, the company has developed ZivoBort and ZivoBurster. ZivoBort is a potential medication aimed at fighting inflammation, while ZivoBurster is a potential medication for combating cancer. Zivo Bioscience Inc has established several business relationships in recent years to sell its products. The company has formed partnerships with animal feed company NutriQuest and pharmaceutical company PharmCoRx. Zivo Bioscience Inc has also collaborated with the University of Arizona and the University of Massachusetts to conduct research in the field of plant biotechnology. Overall, Zivo Bioscience Inc is an innovative company specializing in the development of high-quality food and nutritional supplements from plant sources. The company has already launched several products on the market and is working on developing new products. With its research efforts and business relationships, the company is well-positioned to realize its vision of cost-effective and nutritious animal feed products. Zivo Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Zivo Bioscience's P/S Ratio

Zivo Bioscience's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Zivo Bioscience's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Zivo Bioscience's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Zivo Bioscience’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Zivo Bioscience stock

What is the price-to-earnings ratio of Zivo Bioscience?

The price-earnings ratio of Zivo Bioscience is currently 44.56.

How has the price-earnings ratio of Zivo Bioscience changed compared to last year?

The price-to-earnings ratio of Zivo Bioscience has increased by 4,226.21% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Zivo Bioscience high compared to other companies?

Yes, the price-to-earnings ratio of Zivo Bioscience is high compared to other companies.

How does an increase in the price-earnings ratio of Zivo Bioscience affect the company?

An increase in the price-earnings ratio of Zivo Bioscience would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Zivo Bioscience affect the company?

A decrease in the price-earnings ratio of Zivo Bioscience would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Zivo Bioscience?

Some factors that influence the price-earnings ratio of Zivo Bioscience are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Zivo Bioscience pay?

Over the past 12 months, Zivo Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zivo Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Zivo Bioscience?

The current dividend yield of Zivo Bioscience is .

When does Zivo Bioscience pay dividends?

Zivo Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Zivo Bioscience?

Zivo Bioscience paid dividends every year for the past 0 years.

What is the dividend of Zivo Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Zivo Bioscience located?

Zivo Bioscience is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Zivo Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Zivo Bioscience from 12/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.

When did Zivo Bioscience pay the last dividend?

The last dividend was paid out on 12/12/2024.

What was the dividend of Zivo Bioscience in the year 2023?

In the year 2023, Zivo Bioscience distributed 0 USD as dividends.

In which currency does Zivo Bioscience pay out the dividend?

The dividends of Zivo Bioscience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Zivo Bioscience

Our stock analysis for Zivo Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zivo Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.